GPT Healthcare Q2 FY27 Preview: Trends and Numbers to Watch

Track the latest GPT Healthcare Ltd. share price on Univest. With the September 2026 quarter nearing its end, hospital chain investors are turning attention to the GPT Healthcare Q2 results, the next earnings update for this Kolkata-headquartered healthcare operator. GPT Healthcare has shown a steady improvement in operating margin over the past five quarters even as revenue growth has moderated in the two most recent periods, and that combination frames expectations for the GPT Healthcare Q2 results.

Revenue held near Rs 126 Cr in Q1 FY27 versus Rs 107 Cr in Jun25. OPM improved to 19.05%. CMP Rs 163.61, PE 28.3x.

This preview covers the expected announcement window, the metrics worth watching, actual numbers from the last two reported quarters, and the current valuation, based strictly on historical, publicly disclosed financials rather than any forecast figure.

Ready to track this stock ahead of results? Open a free demat account with Univest.

GPT Healthcare Q2 results Date: When Will GPT Healthcare Announce Q2 FY27 Numbers

GPT Healthcare has not yet officially announced a board meeting date for the GPT Healthcare Q2 results. Based on the company’s historical reporting pattern since its listing, September-quarter results have typically been declared in the second half of October or the first two weeks of November. Investors tracking the GPT Healthcare Q2 results should watch for a formal exchange intimation of the board meeting date closer to that window.

GPT Healthcare Q2 results Expectations: Metrics and Trends to Watch

Also read – Premier Energies Q2 Results FY27 Preview

Ahead of the GPT Healthcare Q2 results, occupancy levels across the company’s hospital beds, average revenue per occupied bed, and case mix between general and specialty treatments are the operational metrics most worth tracking. GPT Healthcare’s OPM has improved from 16.00% in Jun25 to 19.05% in Jun26, its best level in the trailing five-quarter window, even though revenue growth flattened between Mar26 and Jun26. Whether topline growth picks up again while margin holds near recent highs will likely shape how the GPT Healthcare Q2 results are read once declared.

GPT Healthcare Q1 FY27 (Quarter Ended June 2026): Previous Quarter Actuals

In Q1 FY27, the quarter ended June 2026, GPT Healthcare reported revenue of Rs 126 crore, flat compared with Rs 126 crore in Mar26. Operating profit came in at Rs 24 crore with an OPM of 19.05%, its highest level in the series, up from 18.25% in Mar26. Net profit for the quarter was Rs 13 crore, moderating from Rs 15 crore in Mar26 despite the margin improvement. This is the latest actual data point ahead of the GPT Healthcare Q2 results.

GPT Healthcare Q2 FY26 (Quarter Ended September 2025): The Base Quarter

The year-ago quarter the GPT Healthcare Q2 results will be compared against is Q2 FY26. In that quarter, GPT Healthcare posted revenue of Rs 119 crore, operating profit of Rs 23 crore at a 19.00% OPM, and net profit of Rs 11 crore. Revenue in the Jun26 quarter is modestly higher than this base, while margin is only marginally ahead, giving a sense of the year-on-year comparison the GPT Healthcare Q2 results will eventually be measured against.

Want to build a watchlist for earnings season? Open your Univest demat account today.

GPT Healthcare Q2 results: Recent 5-Quarter Trend

Revenue growth has slowed in the two most recent quarters after a sharper rise earlier in the series, while operating margin has stayed in a relatively narrow 16-19% band with an improving bias. This context is worth keeping in mind while reading the GPT Healthcare Q2 results once they arrive.

Key Factors to Watch Ahead of the GPT Healthcare Q2 results

Also read – Indiamart Intermesh Q2 Results FY27 Preview

Bed occupancy rates, growth in specialty treatment volumes, and any update on new bed capacity additions across the company’s hospital network are the operational levers to track. Employee and consumable costs, which directly affect margin in a hospital business, are also worth following ahead of the GPT Healthcare Q2 results.

GPT Healthcare Valuation Snapshot Ahead of the GPT Healthcare Q2 results

At the current market price of Rs 163.61, GPT Healthcare trades at a trailing PE of 28.41x, a price-to-book of 4.99x against a book value of Rs 32.8, and a return on equity of 16.7%. The stock’s 52-week range is Rs 115 to Rs 175, and it currently trades above both its 50-day moving average (Rs 151.63) and 200-day moving average (Rs 144.18), with an RSI of 75.02 pointing to overbought technical territory. The dividend yield is 1.54%.

What to Watch in the GPT Healthcare Q2 results

Beyond the headline numbers, commentary on new hospital or bed additions, occupancy trends across existing facilities, and any change in the mix between general and specialty care will matter for the outlook beyond the September quarter. Margin sustainability near the recent 19% level is likely to be a key focus once the GPT Healthcare Q2 results are declared.

Open a demat account on Univest to start tracking this counter and others like it.

Conclusion: GPT Healthcare Q2 results Outlook

GPT Healthcare enters its reporting window with operating margin at its best level in the trailing five-quarter series, even as revenue growth has flattened over the last two quarters. The GPT Healthcare Q2 results will be watched for whether topline growth reaccelerates while margin holds firm, though actual figures can only be confirmed once the company formally reports them. This article does not offer any buy, sell or hold recommendation.

Univest Securities Private Limited is a SEBI-registered Research Analyst (Registration No. INH000013776). This article is for informational and educational purposes only and does not constitute investment advice, a recommendation, or a solicitation to buy or sell any security. Investors should consult their own financial advisor before making any investment decision.

FAQs

When will GPT Healthcare announce its Q2 FY27 results?

Ans. GPT Healthcare has not officially announced a date for its Q2 FY27 results. Based on past patterns, the company typically reports its September-quarter numbers in late October or early November.

What was GPT Healthcare’s net profit in Q1 FY27?

Ans. In the quarter ended June 2026, GPT Healthcare reported a net profit of Rs 13 crore on revenue of Rs 126 crore, with an operating margin of 19.05%.

How has GPT Healthcare’s operating margin trended recently?

Ans. The operating margin has improved from 16.00% in June 2025 to 19.05% in June 2026, its best level across the trailing five-quarter window.

What is GPT Healthcare’s current valuation?

Ans. As of the latest available data, GPT Healthcare trades at a trailing PE of about 28.4 times with a return on equity of 16.7%, near the higher end of its 52-week range.